Skip to main content

CTT Pharmaceutical Holdings, Inc.

CTTH
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001035422

In the last 90 days, CTT Pharmaceutical Holdings, Inc. insiders filed 14 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Market capNo recent closing price
–
Insider buysLast 90 days, $3.95K in total
14
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2014
–
No comparable prior period
Net income, FY2014
-$672.2K
−708.5% year over year
Free cash flow, FY2014
–
No comparable prior period
Revenue, Q2 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
19.2K
Shares sold short
Change
+1.00K
+5.5% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding CTTH, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CTTH at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by CTT Pharmaceutical Holdings, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2026 (view filing)9:45 AM ETNov 124 daysCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+1.50K$0.054+$810.0%9.45M after
Nov 6, 2026 (view filing)11:13 AM ETNov 42 daysCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+9.00K$0.05+$450+0.1%9.45M after
Oct 26, 2026 (view filing)9:05 PM ETOct 26Same dayCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+5.88K$0.057+$335.16+0.1%9.44M after
Oct 19, 2026 (view filing)5:22 PM ETOct 154 daysCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+2.00K$0.057+$1140.0%9.44M after
Oct 6, 2026 (view filing)5:24 PM ETOct 6Same dayCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+3.70K$0.055+$203.50.0%9.43M after
Sep 29, 2026 (view filing)10:22 AM ETSep 227 daysCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+10.1K$0.045+$454.5+0.1%9.42M afterAmended
Sep 28, 2026 (view filing)9:56 AM ETSep 28Same dayCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+3.40K$0.055+$1870.0%9.43M after
Sep 16, 2026 (view filing)1:19 PM ETSep 16Same dayCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+10.9K$0.048+$523.2+0.1%9.41M after
Sep 10, 2026 (view filing)6:10 PM ETSep 10Same dayCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+3.50K$0.05+$1750.0%9.40M after
Sep 4, 2026 (view filing)4:18 PM ETSep 4Same dayCTT Pharmaceutical Holdings, Inc.CEOPPurchaseCTTH+9.80K$0.0489+$479.22+0.1%9.40M after

Top 10 13F holders, Q2 2026

View all: Top 10 13F holders, Q2 2026

The largest institutional positions in CTT Pharmaceutical Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.

No institution reported holding CTTH in 13F filings for Q2 2026.